Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in DNLI — Denali Therapeutics Inc.

CIK 923093 STAMFORD, CT

Position in DNLI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,053,619
+$167,313 QoQ
Shares Held
40,965
-23.7% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#125
of 290 holders
Holding Since
Jun 2020
13 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. DNLI ranks #57 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,053,619 40,965
2025-12-31 $886,306 53,683
2025-09-30 $818,463 56,368
2025-06-30 $775,717 55,448
2025-03-31 $986,956 72,597
2024-06-30 $1,358,904 58,523
2024-03-31 $1,470,278 71,651
2023-09-30 $866,872 42,020
2023-03-31 $1,275,171 55,346
2022-12-31 $1,388,581 49,931
2022-06-30 $484,535 16,464
2021-03-31 $2,232,952 39,106
2020-06-30 $917,050 37,926